VITAMIN AD INJECTION

Manufacturer
Phoenix Pharmaceutical Inc
Effective date
2018-10-23
Label type
OTC ANIMAL DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:40:18

Label at a glance#

ProductVITAMIN AD
Active ingredientRETINOL, CHOLECALCIFEROL
Label structure6 sections

Dosage and administration

Inject intramuscularly or subcutaneously preferably  in the neck area using aseptic technique. Calves - 1/2 to 1 mL Adult Cattle  - 2 to 4 mL Lambs -  1/4 to 1/2 mL Adult Sheep  - 1 to 2 mL Weaning Pigs  - 1/4 to 1/2 mL Adult Swine  - 1 to 2 mL These suggested dosage may be repeated after 60 days, if necessary. TAKE TIME OBSERVE LABEL DIRECTIONS

Storage and handling

Store at controlled room temperature between 15 o and 30 o C (59-86 o F). Protect from light and excessive heat.

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

INDICATIONS

For use as a supplemental nutritive source of vitamins A and D in cattle, sheep and swine.

CAUTION

PRECAUTIONS SECTION

Do not inject into meat animals within 60 days of marketing. 

Administration of this product to well nourished animals may cause hypervitaminosis D which may result in hypercalcemia.  This condition may be harmful to the animal.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Inject intramuscularly or subcutaneously preferably  in the neck area using aseptic technique.

Calves - 1/2 to 1 mL

Adult Cattle - 2 to 4 mL

Lambs - 1/4 to 1/2 mL

Adult Sheep - 1 to 2 mL

Weaning Pigs - 1/4 to 1/2 mL

Adult Swine - 1 to 2 mL

These suggested dosage may be repeated after 60 days, if necessary.

TAKE TIME OBSERVE LABEL DIRECTIONS

COMPOSITION

COMPONENTS

Each mL of sterile solution contains:
Vitamin A  . . . . . . . . . 500,000 IU
Vitamin D3  . . . . . . . . . 75,000 IU
In an emulsifiable base with vitamin E (antioxidant), N-methylpyrrolidone, polyoxyethylated (30) castor oil, propylene glycol dicaprylate, polyoxyethylene (20) sorbitan monooleate and benzyl alcohol 2%.

STORAGE

STORAGE AND HANDLING SECTION

Store at controlled room temperature between 15o and 30oC (59-86oF).

Protect from light and excessive heat.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PX Vit ADPX Vit AD

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999793vitamin A 500,000 UNT/ML / vitamin D3 75,000 UNT/ML Injectable SolutionPSN1
999793cholecalciferol 75000 UNT/ML / vitamin A 500000 UNT/ML Injectable SolutionSCD1
999793retinol 500,000 UNT/ML / vitamin D3 75,000 UNT/ML Injectable SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHOLECALCIFEROL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
57319-424-06VITAMIN AD250 mL in 1 VIALINJECTION2501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
57319-424VITAMIN AD (RETINOL CHOLECALCIFEROL) INJECTION [PHOENIX PHARMACEUTICAL INC]11 package rows20181024_eaff2256-39c6-4210-b783-5d5cd1a85c6a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57319-42457319-424-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
RETINOLG2SH0XKK91ACTIB
CHOLECALCIFEROL1C6V77QF41ACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.